- Home
- NEO vs TBLA Comparison
NEO vs TBLA Comparison
Compare NEO & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEO | TBLA |
|---|---|---|
| Founded | 2001 | 2007 |
| Country | United States | United States |
| Employees | N/A | 2000 |
| Industry | Precision Instruments | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 952.2M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | NEO | TBLA |
|---|---|---|
| Price | $8.92 | $5.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $13.38 | $5.00 |
| AVG Volume (30 Days) | ★ 2.2M | 2.1M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.63 | $7.63 |
| Revenue Next Year | $9.73 | $5.25 |
| P/E Ratio | ★ N/A | $42.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.72 | $2.84 |
| 52 Week High | $13.74 | $5.22 |
Technical Indicators
Market Signals| Indicator | NEO | TBLA |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 90.49 |
| Support Level | $7.50 | $3.86 |
| Resistance Level | $10.66 | N/A |
| Average True Range (ATR) | 0.61 | 0.21 |
| MACD | 0.07 | 0.14 |
| Stochastic Oscillator | 48.11 | 99.69 |
Price Performance
Historical ComparisonAbout NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About TBLA Taboola.com Ltd.
Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.